Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07743255Enrolling by invitation
Randomised trial of melatonin in migraine (2 arms), sponsored by Nishtar Medical University. Primary endpoints: Change in Monthly Migraine Attack Frequency at 3 months and Change in Migraine Pain Severity at 3 months. Started Jun 2026; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07743255.